China Bispecific Antibodies Market Size & Outlook

The bispecific antibodies market in China is expected to reach a projected revenue of US$ 905.3 million by 2030. A compound annual growth rate of 35.8% is expected of China bispecific antibodies market from 2024 to 2030.
Revenue, 2023 (US$M)
$106.4
Forecast, 2030 (US$M)
$910.4
CAGR, 2024 - 2030
35.9%
Report Coverage
China

China bispecific antibodies market highlights

  • The China bispecific antibodies market generated a revenue of USD 106.4 million in 2023 and is expected to reach USD 910.4 million by 2030.
  • The China market is expected to grow at a CAGR of 35.9% from 2024 to 2030.
  • In terms of segment, cancer was the largest revenue generating type in 2023.
  • Cancer is the most lucrative type segment registering the fastest growth during the forecast period.

Bispecific antibodies market data book summary

Market revenue in 2023USD 106.4 million
Market revenue in 2030USD 910.4 million
Growth rate35.9% (CAGR from 2023 to 2030)
Largest segmentCancer
Fastest growing segmentCancer
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCancer
Key market players worldwideAmgen Inc, Roche Holding AG, Genentech, Akeso Inc Ordinary Shares, Janssen Pharmaceuticals, Taisho Pharmaceutical Holdings Co Ltd ADR, Immunocore Holdings PLC ADR

Other key industry trends

  • In terms of revenue, China accounted for 1.2% of the global bispecific antibodies market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China bispecific antibodies market is projected to lead the regional market in terms of revenue in 2030.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 651.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Bispecific Antibodies Market Scope

Bispecific antibodies market segmentation & scope

Bispecific Antibodies Market Companies

Name Profile # Employees HQ Website

China bispecific antibodies market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bispecific antibodies market will help companies and investors design strategic landscapes.


Cancer was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the China bispecific antibodies market based on cancer covering the revenue growth of each sub-segment from 2018 to 2030.


  • China Bispecific Antibodies Type Outlook (Revenue, USD million, 2018-2030)
    • Inflammatory & Autoimmune Disorders
    • Cancer
    • Others

Reasons to subscribe to China bispecific antibodies market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China bispecific antibodies market databook

  • Our clientele includes a mix of bispecific antibodies market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China bispecific antibodies market , including forecasts for subscribers. This country databook contains high-level insights into China bispecific antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China bispecific antibodies market size, by type, 2018-2030 (US$M)

China Bispecific Antibodies Market Outlook Share, 2023 & 2030 (US$M)

China bispecific antibodies market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more